About NovaXS
NovaXS is a smart medical device startup on a mission to simplify the medication administration process and improve treatment outcome with our patent-pending smart needle-free drug delivery platform, Telosis.
Our vision
To build a needle-free, transformative, and interactive drug delivery platform and present to the market a world-leading and life-changing biological proteins that treat chronic diseases.
Reed
McCalmon
(CFO)
10+ years Experience in Biotech Finance
Shuhua
Zhang
(Software Director)
Entrepreneur, 5+ years in SDE, AWS Certified Solution Architect
Haley E.
Titus, PhD
(VP of Clinical Operations)
NU FSM Neuroimmunologist,
15+ years in Translational Medicine
Jim
McAvoy
(Business Development Lead)
35+ years of sales and lead-generation experience
Eric
Pulver
(Scientific Advisor)
Healthcare innovator/entrepreneur,
Former Director Oral Maxillofacial Surgery University of Chicago Hospital
Fred
Zussa
(Board Advisor)
Chief Business Officer,
MIT MBA & Telecom Paris Tech Engineer
Sean
McKibben
(Board Advisor)
Head of Doctors Relations,
Former Hospital President
James G.
Wetrich
(Board Advisor)
Reapplix Former President
David
Harrell
(Board Advisor)
OptimizeRX - NASDAQ: OPRX former CEO
Meet the Team
NovaXS is founded out of UC Berkeley QB3 Laboratory
led by world-famous regenerative medicine expert Professor Irina Conboy and a professional team in healthcare
with a proven track record of over 40 million fundraising experience and 5 successful business exits.
Alina
Su
(CEO & Founder)
HMS PhD Candidate, Medical Device Inventor
Jonathan
(COO & Co-Founder)
Booth MBA, Serial Entrepreneur
Alex
Zou
(CTO & Co-founder)
UC Berkeley Electro- engineering PhD
Irina
Conboy PhD
(Chief Scientfic Advisor)
UC Berkeley Bioengineering Professor
